Amryt Pharma (AMYT) – Investor presentation at ShareSoc September 2018

2018-09-25

the full video can be seen at: https://www.piworld.co.uk/2018/09/25/amryt-pharma-amyt-investor-presentation-at-sharesoc-september-2018/ Presentation by Amryt Pharma CCO, David Allmond. Amryt Pharma plc is a commercial-stage specialty pharmaceutical company focused on developing and delivering treatments for patients with rare and orphan diseases. The Company is building a diversified portfolio of proprietary drugs to help address some of rare and debilitating illnesses. The team – 00:27The vision - 02...

the full video can be seen at: https://www.piworld.co.uk/2018/09/25/amryt-pharma-amyt-investor-presentation-at-sharesoc-september-2018/

Presentation by Amryt Pharma CCO, David Allmond. Amryt Pharma plc is a commercial-stage specialty pharmaceutical company focused on developing and delivering treatments for patients with rare and orphan diseases. The Company is building a diversified portfolio of proprietary drugs to help address some of rare and debilitating illnesses.

The team – 00:27
The vision - 02:12
Amryt overview – 04:04
Commercial & development pipeline - 06:00
Strategy – 3 pillars of growth - 07:43
Lojuxta - 10:02
Epidermolysis Bullosa (EB) AP101 - 12:20
AP103 – building an EB franchise - Gene Therapy Platform - 18:26
In-License Opportunities - 21:07
Financials - 22:16
Investment case - 22:55
Q&A - 24:18

Comments (3)